Growing Interest in Regenerative Medicine to Drive the Mesenchymal Stem Cells Market, According to a Soon to Be Released Report by Global Industry Analysts, Inc.

GIA announces the launch of a comprehensive primary research program studying the global market for “Mesenchymal Stem Cells (MSCs)”. The soon to be released report identifies increased investments in MSC research, development of new research tools, and expanding therapeutic solutions, as key market driving forces.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Mesenchymal Stem Cells (MSCs): A Global Multi-Client Research Initiative

San Jose, CA (PRWEB) December 05, 2013

Follow us on LinkedIn – GIA invites senior industry executives, domain experts, technologists and market strategists to participate in a comprehensive global research initiative studying the “Mesenchymal Stem Cells (MSCs)” markets. The study will examine key drivers and trends impacting the market such as increased investments in MSC research; advances in autologous MSCs; rise in the number of patent applications in the field of human tissue regeneration; growing prominence of oncology, orthopedics, inflammatory disorders, and cardiology as lucrative therapeutic application areas; and growing interest in the use of MSCs for providing personalized cell therapy for autoimmune diseases.

A rapidly growing area of stem cell research, Mesenchymal Stem Cells (MSCs) are defined as progenitor cells capable of producing multiple types of specialized cells in the body such as, osteoblasts, chondrocytes, adipocytes, myocytes, and neuronal cells. MSCs reside in bone marrow and other tissues such as umbilical cord, fat and muscle tissues. Ability of MSCs to repair tissue damage is resulting in increased interest in MSC based research in the field of tissue engineering and regenerative medicine. The last few years have witnessed significant increase in the number of clinical studies focused on MSC based bone and cartilage repair, heart and blood vessel repair. With cellular therapies now emerging as the new frontier of modern medical treatment, MSCs based regenerative approaches to treating neurological diseases is expected to bring in new opportunities for growth in the market. Breakthrough developments in delivery of MSCs through intracerebral or intrathecal injections remain critical for successful commercialization of MSC-based cellular therapies for neurodegenerative disorders. The market is also expected to benefit from increased use of MSCs in cell-based screening assays, such as, siRNA screening and biomolecule screening. In addition, cutting edge developments in genetically engineered MSCs as delivery vehicles for treatment will largely influence future market growth.

Other promising application areas include use of MSCs as immunomodulators in treating graft-versus-host (GVHD) disease, preventing transplant rejection, to enhance islet transplantation success in treatment of type I diabetes, and as anti-cancer agents in cancer treatment. MSC-based cancer therapies especially are expected to witness strong R&D interest, given the tumor-trophic migratory properties of MSCs. The study estimates Mesenchymal Stem Cells (MSCs) to be a multi-million dollar market worldwide, while more precise market-size and growth projections will be made available during the 2nd stage of report preparation, and data analysis.

The research and analyses will be released shortly in the form of a comprehensive research report. The report by design, will attempt to provide exhaustive analysis, data, trends, market share, market size, statistics, forecasts and competitive intelligence. The report is modeled to offer precise and unbiased, actionable market insights including in-depth segmentation of market sub-sectors, demand estimates and projections and analysis of trends in each of the sectors, identification of leading players, and the competitive structure, among others.

Developed for Drug Developers, Strategic Planners, Business Development Executives, Management Consultants, Investment Bankers, Consulting Firms, Marketing & Sales Executives, C-Level Decision Makers, Market Strategists and Technology Domain Experts, the report helps identify the biggest opportunities in this space and offers accurate latent demand forecasting that empowers quantitative decision making among existing market players and new entrants.

For more details about how you can participate, please click here.

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/


Contact

Attachments